Thank you.
Merci, monsieur Arthur.
We're going to be going to the motion in about five minutes, so I have time for a few brief questions.
I want to start with Ms. Dodds. In your presentation you said that federal regulatory approval times for new drugs have continued to improve over the last few years. That's certainly what I've heard, that the times have been improved. But I have heard—and this is just anecdotal evidence, so I'm going to ask you about it—that there is quite an approval backlog for natural health products.
Can you give us some figures or facts, either here or later on, that would indicate what the approval times are for natural health products and whether they are getting better or getting slower?